ArticleFrontiers in genetics2022

Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker.

Chi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.